AAAAAA

   
Results: 1-13 |
Results: 13
Rapid access to N-Boc phenylglycine derivatives via benzylic lithiation reactions
Authors: Barberis, C Voyer, N Roby, J Chenard, S Tremblay, M Labrie, P
Citation: C. Barberis et al., Rapid access to N-Boc phenylglycine derivatives via benzylic lithiation reactions, TETRAHEDRON, 57(15), 2001, pp. 2965-2972
Diagnosis and treatment of Helicobacter pylori infection. Relationship with gastroduodenal ulcer and antimicrobial resistance.
Authors: Antelo, P Almuzara, M Avagnina, A Topor, J Barberis, C Barcia, T Araujo, G Vay, C Famiglietti, A
Citation: P. Antelo et al., Diagnosis and treatment of Helicobacter pylori infection. Relationship with gastroduodenal ulcer and antimicrobial resistance., MEDICINA, 61(5), 2001, pp. 545-551
Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist
Authors: Carnazzi, E Aumelas, A Mouillac, B Breton, C Guillou, L Barberis, C Seyer, R
Citation: E. Carnazzi et al., Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist, J MED CHEM, 44(18), 2001, pp. 3022-3030
Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist - Comparison with the human V-1a vasopressin receptor
Authors: Breton, C Chellil, H Kabbaj-Benmansour, M Carnazzi, E Seyer, R Phalipou, S Morin, D Durroux, T Zingg, H Barberis, C Mouillac, B
Citation: C. Breton et al., Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist - Comparison with the human V-1a vasopressin receptor, J BIOL CHEM, 276(29), 2001, pp. 26931-26941
Diagnosis of Helicobacter pylori infection: Noninvasive methods compared to invasive methods and evaluation of two new tests
Authors: Monteiro, L de Mascarel, A Sarrasqueta, AM Bergey, B Barberis, C Talby, P Roux, D Shouler, L Goldfain, D Lamouliatte, H Megraud, F
Citation: L. Monteiro et al., Diagnosis of Helicobacter pylori infection: Noninvasive methods compared to invasive methods and evaluation of two new tests, AM J GASTRO, 96(2), 2001, pp. 353-358
Conserved aromatic residues in the transmembrane region VI of the V-1a vasopressin receptor differentiate agonist vs. antagonist ligand binding
Authors: Cotte, N Balestre, MN Aumelas, A Mahe, E Phalipou, S Morin, D Hibert, M Manning, M Durroux, T Barberis, C Mouillac, B
Citation: N. Cotte et al., Conserved aromatic residues in the transmembrane region VI of the V-1a vasopressin receptor differentiate agonist vs. antagonist ligand binding, EUR J BIOCH, 267(13), 2000, pp. 4253-4263
Functional architecture of vasopressin/oxytocin receptors
Authors: Hibert, M Hoflack, J Trumpp-Kallmeyer, S Mouillac, B Chini, B Mahe, E Cotte, N Jard, S Manning, M Barberis, C
Citation: M. Hibert et al., Functional architecture of vasopressin/oxytocin receptors, J RECEPT SI, 19(1-4), 1999, pp. 589-596
Synthesis of both enantiomers of phenylglycine using (-)-sparteine
Authors: Barberis, C Voyer, N
Citation: C. Barberis et N. Voyer, Synthesis of both enantiomers of phenylglycine using (-)-sparteine, SYNLETT, (7), 1999, pp. 1106-1108
Cefotaxime-hydrolysing beta lactamases in Morganella morganii
Authors: Power, P Radice, M Barberis, C de Mier, C Mollerach, M Maltagliatti, M Vay, C Famiglietti, A Gutkind, G
Citation: P. Power et al., Cefotaxime-hydrolysing beta lactamases in Morganella morganii, EUR J CL M, 18(10), 1999, pp. 743-747
Fluorescent pseudo-peptide linear vasopressin antagonists: Design, synthesis, and applications
Authors: Durroux, T Peter, M Turcatti, G Chollet, A Balestre, MN Barberis, C Seyer, R
Citation: T. Durroux et al., Fluorescent pseudo-peptide linear vasopressin antagonists: Design, synthesis, and applications, J MED CHEM, 42(7), 1999, pp. 1312-1319
Docking of linear peptide antagonists into the human V-1a vasopressin receptor - Identification of binding domains by photoaffinity labeling
Authors: Phalipou, S Seyer, R Cotte, N Breton, C Barberis, C Hibert, M Mouillac, B
Citation: S. Phalipou et al., Docking of linear peptide antagonists into the human V-1a vasopressin receptor - Identification of binding domains by photoaffinity labeling, J BIOL CHEM, 274(33), 1999, pp. 23316-23327
The D136A mutation of the V-2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities
Authors: Morin, D Cotte, N Balestre, MN Mouillac, B Manning, M Breton, C Barberis, C
Citation: D. Morin et al., The D136A mutation of the V-2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities, FEBS LETTER, 441(3), 1998, pp. 470-475
The vasopressin V2 receptor: molecular basis of the nephrogenic diabetes insipidus and identification of residues responsible for binding selectivity
Authors: Morin, D Cotte, N Phalipou, S Balestre, MN Ala, Y Sabatier, N Jard, S Vargas, R Antignac, C Dechaux, M Arthus, M Lonergan, M Turner, MS Bichet, DG Hendy, GN Alonso, G Manning, M Hibert, M Mouillac, B Barberis, C
Citation: D. Morin et al., The vasopressin V2 receptor: molecular basis of the nephrogenic diabetes insipidus and identification of residues responsible for binding selectivity, HYDRATION THROUGHOUT LIFE, 1998, pp. 215-221
Risultati: 1-13 |